Frederic Preffer

Title: Frederic Preffer: Innovator in Ovarian Cancer Research

Introduction

Frederic Preffer is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly in the area of ovarian cancer. His innovative work focuses on the treatment, characterization, and diagnosis of ovarian cancer, which is a critical area of study given the disease's impact on women's health.

Latest Patents

Frederic Preffer holds a patent for "Collecting ovarian cancer stem cells from ovarian cancer cells." This invention relates to compositions and methods for treating, characterizing, and diagnosing ovarian cancer. The patent outlines methods for treating and/or preventing ovarian cancer by administering effective amounts of Mullerian Inhibiting substance and/or agents that inhibit BCRP1. Additionally, it provides methods to identify and enrich populations of ovarian cancer stem cells and somatic ovarian stem cells, including specific markers for these cells.

Career Highlights

Frederic Preffer is associated with The General Hospital Corporation, where he continues to advance his research in ovarian cancer. His work is pivotal in developing new therapeutic strategies that could improve patient outcomes.

Collaborations

Frederic has collaborated with notable colleagues such as David Michael Dombkowski and Rafael Pieretti-Vanmarcke. These collaborations enhance the research efforts and contribute to the advancement of knowledge in the field of oncology.

Conclusion

Frederic Preffer's contributions to ovarian cancer research through his innovative patent and collaborative efforts highlight his commitment to improving cancer treatment and diagnosis. His work is essential in the ongoing fight against ovarian cancer, and it underscores the importance of innovation in medical research.